N-Ras Mutation in acute myeloid leukemia: Incidence, prognostic significance and value as a marker of minimal residual disease

References

• Bos J L. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682
   PubMed Web of Science ®Google Scholar
• Bos J L, Toksoz D, Marshall C J. Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia. Nature 1985; 315: 726
   PubMed Web of Science ®Google Scholar
• Varmus H E. The molecular genetics of cellular oncogenes. Annu Rev Genet 1984; 18: 553
   PubMed Web of Science ®Google Scholar
• Barbacid M. Ras genes. Ann Rev Biochem 1987; 56: 779
   PubMed Web of Science ®Google Scholar
• Needleman S W, Kraus M H, Srivastava S K, Levine P H, Aaronson S A. High frequency of N-ras activation in acute myelogenous leukaemia. Blood 1986; 67: 753
   PubMed Web of Science ®Google Scholar
• Janssen J WG, Steenvoorden A CM, Lyons J. RAS gene mutations in acute and chronic myelocytic leukaemias, chronic myeloproliferative disorders and myelodisplastic syndromes. Proc Natl Acad Sci USA 1987; 84: 9228
   PubMed Web of Science ®Google Scholar
• Senn H P, Tran-Thang C H, Wodnar-Filipowicz A. Mutation analysis of N-ras proto-oncogene in active and remission phase of human acute leukaemias. Int J Cancer 1988; 41: 59
   PubMed Web of Science ®Google Scholar
• Bos J L, Verlaan de Vries M, Van der Eb A J. Mutations in N-ras predominate in acute myeloid leukaemia. Blood 1987; 69: 1237
   PubMed Web of Science ®Google Scholar
• Juttner C A, To L B, Ho J QK. Early lympho-hemopoietic recovery after autografting using peripheral blood stem cells in acute non-lymphocytic leukaemia. Transplantation Proceedings 1988; Vol XX(1)40
   Google Scholar
• To L B, Russell J, Moore S, Juttner C A. Residual leukaemia cannot be detected in very early remission peripheral blood stem cell collections in acute non-lymphoblastic leukaemia. Leuk Res 1987; 11: 327
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T. Proposals for the classification of the acute leukaemias. French-American-British (FAB) Co-operative group. Br J Haematol 1976; 33: 451
   PubMed Web of Science ®Google Scholar
• Petro R, Pike M C, Armitage P. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977; 35: 1
   PubMedGoogle Scholar
• Verlaan-deVries M, Bogaard M E, Van der Elst H, Van Boom J H, Van der EB AJ, Bos J L. A dot blot screening procedure for mutated ras oncogenes using synthetic oligonucleotides. Gene 1986; 50: 313
   PubMedGoogle Scholar
• Lyons J, Janssen J WG, Bartram C, Layton M, Mufti G J. Mutation of Ki-ras and N-ras Oncogenes in Myelodysplastic Syndromes. Blood 1988; 71: 1707
   PubMed Web of Science ®Google Scholar
• Farr C J, Saiki R K, Erlich H A, McCormick F, Marshall C J. Analysis of ras gene mutations in acute myeloid leukaemia by polymerase chain reaction and oligonucloetide probes. Proc Natl Acad Sci USA 1988; 85: 1629
   PubMed Web of Science ®Google Scholar
• Browett P J, Norton J D. Analysis of ras gene mutations and methy-lation state in human leukaemia. Oncogene 1989; 4: 1029
   PubMed Web of Science ®Google Scholar
• Toksoz D, Farr C J, Marshall C J. Ras gene activation in a minor proportion of the blast population in acute myeloid leukaemia. Oncogene 1987; 1: 409
   PubMed Web of Science ®Google Scholar
• Bartram C R, Ludwig W-D, Hiddemann W. Acute myeloid leukaemia: Analysis of ras gene mutations and clonality defined by polymorphic X-linked loci. Leukaemia 1989; 3: 247
   PubMed Web of Science ®Google Scholar
• Ahuja H G, Foti A, Bar-Eli, Cline M J. The pattern of mutational involvement of Ras genes in human haematologic malignancies by DNA amplification and direct sequencing. Blood 1990; 75: 1684
   PubMed Web of Science ®Google Scholar
• Mane S M, Meltzer S J, Gutheil J C, Kapil V, Lee E J, Needleman S W. Ras gene activation in acute myelogenous leukaemia: Analysis by in vitro amplification and DNA base sequence determination. Genes Chromosomes & Cancer 1990; 2: 71
   PubMed Web of Science ®Google Scholar
• Radich J P, Kopecky K J, Willman C L. N-ras mutations in adult de novo acute myelogenous leukaemia: Prevalence and clinical significance. Blood 1990; 76: 801
   PubMed Web of Science ®Google Scholar
• Ehlen T, Dubeau L. Detection of ras point mutations by polymerase chain reaction using mutation-specific inosine-containing oligonucleotide primers. Biochem Biophys Res Commun 1989; 160: 441
   PubMed Web of Science ®Google Scholar
• Newton C R, Graham A, Heptinstall L E. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucl Acids Res 1989; 17: 2503
   PubMed Web of Science ®Google Scholar
• Haliassos A, Chomel J C, Grandjouan S, Kruh J, Kaplan J C, Kitzis A. Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers. Nucleic Acid Res 1989; 17: 8093
   PubMed Web of Science ®Google Scholar
• Todd A V, Ireland C M, Radloff T J, Kronenberg H, Hand H. Analysis of N-ras mutations in acute myeloid leukaemia by allele specific restriction analysis. Amer J Haemat 1991; 38: 207
   PubMedGoogle Scholar
• Kumar R, Barbacid M. Oncogene detection at the single cell level. Oncogene 1988; 3: 647
   PubMed Web of Science ®Google Scholar
• Todd A V, Ireland C M, Hand H. Allele specific enrichment: A method for the detection of low level N-ras gene mutations in acute myeloid leukaemia. Leukaemia 1991; 5: 160
   PubMedGoogle Scholar
• Levi S, Urbano-Ispizua A, Gill R. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991; 51: 3497
   PubMedGoogle Scholar
• Kahn S M, Jiang W, Culbertson T A. Rapid and sensitive nonradioactive detection of mutant K-ras genes via “enriched” PCR amplification. Oncogene 1991; 6: 1079
   PubMed Web of Science ®Google Scholar
• Coghlan D W, Morley A A, Matthews J, Bishop J. Abstract presented at the twenty-ninth meeting of the Haematology Society of Australia, Melbourne, 1991
   Google Scholar
• Delage R, Soiffer R J, Dear K, Ritz J. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukaemia. Blood 1991; 78: 2759
   PubMed Web of Science ®Google Scholar
• Senn H P, Jiricny J, Fopp M, Schmid L, Morini Ch. Relapse cell population differs from acute onset clone as shown by absence of initially activated N-ras oncogene in a patient with acute myelomonocytic leukaemia. Blood 1988; 72: 931
   PubMed Web of Science ®Google Scholar
• Terada N, Miyoshi J, Kawa-Ha K. Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukaemia. Blood 1990; 75: 453
   PubMed Web of Science ®Google Scholar
• Farr C, Gill R, Katz F, Gibbons B, Marshall C J. Analysis of ras gene mutations in childhood myeloid leukaemia. Brit J Haemat 1991; 77: 323
   PubMed Web of Science ®Google Scholar
• Bashey A, Gill R, Levi S. Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukaemia (AML): Implications for the role of N-ras mutation in AML pathogenesis. Blood 1992; 79: 981
   PubMed Web of Science ®Google Scholar
• Shen W PV, Aldrich T H, Venta-Perez G, Franza B R, Furth M E. Expression of normal and mutant ras proteins in human acute leukaemia. Oncogene 1987; 1: 157
   PubMed Web of Science ®Google Scholar